Download PDF
Vet Comp Orthop Traumatol 2020; 33(04): 243-251
DOI: 10.1055/s-0040-1703008
Original Research
Georg Thieme Verlag KG Stuttgart · New York

Co-administration of Erythromycin and Leech Salivary Extract Alleviates Osteomyelitis in Rats Induced by Methicillin-Resistant Staphylococcus aureus

Bahar Gerivani
1   Department of Pathobiology, Faculty of Veterinary Medicine, Semnan University, Semnan, Iran (the Islamic Republic of)
,
Hamid Staji 
1   Department of Pathobiology, Faculty of Veterinary Medicine, Semnan University, Semnan, Iran (the Islamic Republic of)
,
Maryam Rassouli
1   Department of Pathobiology, Faculty of Veterinary Medicine, Semnan University, Semnan, Iran (the Islamic Republic of)
,
Nooshin Ghazaleh
2   Department of Clinical Sciences, Faculty of Veterinary Medicine, Semnan University, Semnan, Iran (the Islamic Republic of)
,
Abbas Javaheri Vayeghan
1   Department of Pathobiology, Faculty of Veterinary Medicine, Semnan University, Semnan, Iran (the Islamic Republic of)
› Author Affiliations
Further Information

Publication History

13 February 2019

18 January 2020

Publication Date:
30 April 2020 (online)

    Permissions and Reprints

Abstract

Objective Erythromycin (Ery) and leech saliva (LS) can inhibit Staphylococcus aureus growth in in vitro conditions. This study aimed to evaluate the activities and synergy between Ery and LS on chronic osteomyelitis in male Wistar rat's tibia induced by methicillin-resistant S. aureus (MRSA).

Materials and Methods Four weeks after osteomyelitis induction, rats were divided into four groups including no treatment (control), Ery monotherapy (orally), LS monotherapy, or Ery + LS twice daily for 2 weeks. Staphylococcus aureus growth, pathological signs and inflammatory cytokine tumour necrosis factor-alpha (TNF-α) levels were assessed.

Results Rats tolerated all therapeutic strategies well during the experiment. The Ery treatment alone significantly decreased bacterial growth, pathological signs and TNF-α levels. Leech saliva alone reduced TNF-α level significantly, but did not produce a significant reduction in bacterial growth and pathological signs. Ery + LS treatment significantly decreased bacterial growth, considerably alleviated bone pathological signs and decreased TNF-α levels compared with other groups. Statistical analysis suggested that there was a stronger efficiency and synergistic action of Ery and LS when combined against MRSA-induced osteomyelitis in rats.

Clinical Significance The present study suggests that LS may have clinical utility to treat MRSA-induced osteomyelitis when combined with Ery or other therapeutics.

Keywords

methicillin-resistant Staphylococcus aureus - osteomyelitis - leech therapy - erythromycin

Authors' Contributions

Hamid Staji and Maryam Rassouli generated hypothesis, experimental design, real-time polymerase chain reaction experiment and LS extraction. Bahareh Gerivani, Nooshin Ghazaleh and Abbas Javaheri Vayeghan conducted the experiments including surgery, pathology and enzyme-linked immunosorbent assay. Hamid Staji and Maryam Rassouli interpreted and analysed the results and wrote the manuscript. All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for author contributions for this manuscript, take responsibility for the integrity of the work as a whole and have given final approval to the version to be published.


 

  • References

  • 1 Geurts J, Hohnen A, Vranken T, Moh P. Treatment strategies for chronic osteomyelitis in low- and middle-income countries: systematic review. Trop Med Int Health 2017; 22 (09) 1054-1062
    CrossrefPubMedGoogle Scholar
  • 2 Beck-Broichsitter BE, Smeets R, Heiland M. Current concepts in pathogenesis of acute and chronic osteomyelitis. Curr Opin Infect Dis 2015; 28 (03) 240-245
    CrossrefPubMedGoogle Scholar
  • 3 Mast NH, Horwitz D. Osteomyelitis: a review of current literature and concepts. Oper Tech Orthop 2002; 4: 232-241
    CrossrefPubMedGoogle Scholar
  • 4 Azab MA, Allen MJ, Daniels JB. Evaluation of a silver-impregnated coating to inhibit colonization of orthopaedic implants by biofilm forming methicillin-resistant Staphylococcus pseudintermedius . Vet Comp Orthop Traumatol 2016; 29 (04) 347-350
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Vergidis P, Schmidt-Malan SM, Mandrekar JN, Steckelberg JM, Patel R. Comparative activities of vancomycin, tigecycline and rifampin in a rat model of methicillin-resistant Staphylococcus aureus osteomyelitis. J Infect 2015; 70 (06) 609-615
    CrossrefPubMedGoogle Scholar
  • 6 Zhou Z, Pan C, Lu Y. , et al. Combination of erythromycin and curcumin alleviates Staphylococcus aureus induced osteomyelitis in rats. Front Cell Infect Microbiol 2017; 7: 379
    CrossrefPubMedGoogle Scholar
  • 7 Abdualkader AM, Ghawi AM, Alaama M, Awang M, Merzouk A. Leech therapeutic applications. Indian J Pharm Sci 2013; 75 (02) 127-137
    PubMedGoogle Scholar
  • 8 Pereira RF, Bártolo PJ. Traditional therapies for skin wound healing. Adv Wound Care (New Rochelle) 2016; 5 (05) 208-229
    CrossrefPubMedGoogle Scholar
  • 9 Cooper EL, Mologne N. Exploiting leech saliva to treat osteoarthritis: a provocative perspective. J Tradit Complement Med 2016; 7 (03) 367-369
    CrossrefPubMedGoogle Scholar
  • 10 Desaki M, Okazaki H, Sunazuka T, Omura S, Yamamoto K, Takizawa H. Molecular mechanisms of anti-inflammatory action of erythromycin in human bronchial epithelial cells: possible role in the signaling pathway that regulates nuclear factor-kappaB activation. Antimicrob Agents Chemother 2004; 48 (05) 1581-1585
    CrossrefPubMedGoogle Scholar
  • 11 Amsden GW. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?. J Antimicrob Chemother 2005; 55 (01) 10-21
    CrossrefPubMedGoogle Scholar
  • 12 Jelić D, Antolović R. From erythromycin to azithromycin and new potential ribosome-binding antimicrobials. Antibiotics (Basel) 2016; 5 (03) 29
    CrossrefPubMedGoogle Scholar
  • 13 Sig AK, Guney M, Uskudar Guclu A, Ozmen E. Medicinal leech therapy-an overall perspective. Integr Med Res 2017; 6 (04) 337-343
    Google Scholar
  • 14 Nutt EM, Jain D, Lenny AB, Schaffer L, Siegl PK, Dunwiddie CT. Purification and characterization of recombinant antistasin: a leech-derived inhibitor of coagulation factor Xa. Arch Biochem Biophys 1991; 285 (01) 37-44
    CrossrefPubMedGoogle Scholar
  • 15 Zaidi SM, Jameel SS, Zaman F, Jilani S, Sultana A, Khan SA. A systematic overview of the medicinal importance of sanguivorous leeches. Altern Med Rev 2011; 16 (01) 59-65
    PubMedGoogle Scholar
  • 16 Das BK. An overview on hirudotherapy/leech therapy. Ind Res J Pharm Sci 2014; 1: 33-45
    PubMedGoogle Scholar
  • 17 Abdullah S, Dar LM, Rashid A, Tewari A. Hirudotherapy/leech therapy: applications and indications in surgery. Arch Clin Exp Surg 2012; 1: 172-180
    CrossrefPubMedGoogle Scholar
  • 18 Sobczak N, Kantyka M. Hirudotherapy in veterinary medicine. Ann Parasitol 2014; 60 (02) 89-92
    PubMedGoogle Scholar
  • 19 Weinfeld AB, Yuksel E, Boutros S, Gura DH, Akyurek M, Friedman JD. Clinical and scientific considerations in leech therapy for the management of acute venous congestion: an updated review. Ann Plast Surg 2000; 45 (02) 207-212
    CrossrefPubMedGoogle Scholar
  • 20 Ahirrao R, Jadhav J, Pawar S. A review on leech therapy. Pharma Sci Monit 2017; 8: 228-237
    PubMedGoogle Scholar
  • 21 de Chalain TM. Exploring the use of the medicinal leech: a clinical risk-benefit analysis. J Reconstr Microsurg 1996; 12 (03) 165-172
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Darestani KD, Mirghazanfari SM, Moghaddam KG, Hejazi S. Leech therapy for linear incisional skin-wound healing in rats. J Acupunct Meridian Stud 2014; 7 (04) 194-201
    CrossrefPubMedGoogle Scholar
  • 23 Hajighorbani M, Ahmadi-Hamedani M, Shahab E. , et al. Evaluation of the protective effect of pentoxifylline on carrageenan-induced chronic non-bacterial prostatitis in rats. Inflammopharmacology 2017; 25 (03) 343-350
    CrossrefPubMedGoogle Scholar
  • 24 Curtin LI, Grakowsky JA, Suarez M. , et al. Evaluation of buprenorphine in a postoperative pain model in rats. Comp Med 2009; 59 (01) 60-71
    PubMedGoogle Scholar
  • 25 An YH, Friedman RJ. Animal models of orthopedic implant infection. J Invest Surg 1998; 11 (02) 139-146
    CrossrefPubMedGoogle Scholar
  • 26 Lucke M, Schmidmaier G, Sadoni S. , et al. A new model of implant-related osteomyelitis in rats. J Biomed Mater Res B Appl Biomater 2003; 67 (01) 593-602
    CrossrefPubMedGoogle Scholar
  • 27 Gasic GJ, Viner ED, Budzynski AZ, Gasic GP. Inhibition of lung tumor colonization by leech salivary gland extracts from Haementeria ghilianii . Cancer Res 1983; 43 (04) 1633-1635
    PubMedGoogle Scholar
  • 28 Güzel Y, Golge UH, Goksel F. , et al. The efficacy of boric acid used to treat experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus: an in vivo study. Biol Trace Elem Res 2016; 173 (02) 384-389
    CrossrefPubMedGoogle Scholar
  • 29 Trung NT, Hien TT, Huyen TT. , et al. Simple multiplex PCR assays to detect common pathogens and associated genes encoding for acquired extended spectrum beta lactamases (ESBL) or carbapenemases from surgical site specimens in Vietnam. Ann Clin Microbiol Antimicrob 2015; 14: 23
    CrossrefPubMedGoogle Scholar
  • 30 Kralik P, Ricchi M. A basic guide to real time PCR in microbial diagnostics: definitions, parameters, and everything. Front Microbiol 2017; 8: 108
    CrossrefPubMedGoogle Scholar
  • 31 Tasiemski A. Antimicrobial peptides in annelids. Invertebrate Surviv J 2008; 5: 75-82
    PubMedGoogle Scholar
  • 32 Bagcigil FA, Moodley A, Baptiste KE, Jensen VF, Guardabassi L. Occurrence, species distribution, antimicrobial resistance and clonality of methicillin- and erythromycin-resistant staphylococci in the nasal cavity of domestic animals. Vet Microbiol 2007; 121 (3-4): 307-315
    CrossrefPubMedGoogle Scholar
  • 33 Ellington JK, Harris M, Hudson MC, Vishin S, Webb LX, Sherertz R. Intracellular Staphylococcus aureus and antibiotic resistance: implications for treatment of staphylococcal osteomyelitis. J Orthop Res 2006; 24 (01) 87-93
    CrossrefPubMedGoogle Scholar
  • 34 Westh H, Knudsen AM, Gottschau A, Rosdahl VT. Evolution of Staphylococcus aureus resistance to erythromycin in Denmark, 1959 to 1988: correlations between characteristics of erythromycin-resistant bacteraemia strains. J Hosp Infect 1991; 18 (01) 35-43
    CrossrefPubMedGoogle Scholar
  • 35 Hildebrandt JP, Lemke S. Small bite, large impact-saliva and salivary molecules in the medicinal leech, Hirudo medicinalis . Naturwissenschaften 2011; 98 (12) 995-1008
    CrossrefPubMedGoogle Scholar
  • 36 Nich C, Takakubo Y, Pajarinen J. , et al. Macrophages-key cells in the response to wear debris from joint replacements. J Biomed Mater Res A 2013; 101 (10) 3033-3045
    CrossrefPubMedGoogle Scholar
  • 37 Loi F, Córdova LA, Pajarinen J, Lin TH, Yao Z, Goodman SB. Inflammation, fracture and bone repair. Bone 2016; 86: 119-130
    CrossrefPubMedGoogle Scholar
  • 38 Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci 2008; 13: 453-461
    CrossrefPubMedGoogle Scholar
  • 39 Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 2013; 229 (02) 176-185
    CrossrefPubMedGoogle Scholar
  • 40 Schultz MJ, Speelman P, van der Poll T. Erythromycin inhibits Pseudomonas aeruginosa-induced tumour necrosis factor-α production in human whole blood. J Antimicrob Chemother 2001; 48 (02) 275-278
    CrossrefPubMedGoogle Scholar